Slowly progressive cutaneous, rhinofacial, and pulmonary mucormycosis caused by Mucor irregularis in an immunocompetent woman

Clinical Infectious Diseases

Volumn 56, Issue 7, 2013, Pages 993-995

  Xia, Zhi Kuan ^a   Wang, Wen Ling ^a   Yang, Rong Ya ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cutaneous mucormycosis; Mucor irregularis; Mucormycosis; Pulmonary mucormycosis; Rhinofacial mucormycosis

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE;

ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUTANEOUS MUCORMYCOSIS; DEBRIDEMENT; FEMALE; FIBERSCOPE ENDOSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; LUNG BIOPSY; MINIMUM INHIBITORY CONCENTRATION; MUCOR; MUCOR IRREGULARIS; MUCORMYCOSIS; MYCELIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULMONARY MUCORMYCOSIS; REVIEW; RHINOFACIAL MUCORMYCOSIS;

ADULT; ANTIFUNGAL AGENTS; DEBRIDEMENT; DNA, FUNGAL; FACIAL DERMATOSES; FEMALE; HUMANS; LUNG DISEASES, FUNGAL; MOLECULAR SEQUENCE DATA; MUCOR; MUCORMYCOSIS; NOSE DISEASES; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

EID: 84875013832     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis1045     Document Type: Review

References (11)

1. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012; 54:S23-34.
2. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18: 556-69.
3. Wang SB, Li RY, Yu J. Identification and susceptibility of Rhizomucor spp. isolated from patients with cutaneous zygomycosis in China. Med Mycol 2011; 49: 799-805.
4. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236-301.
5. Zheng RY, Chen CQ. A non-thermophilic Rhizomucor causing human primary cutaneous mucormycosis. Mycosystema 1991; 4: 45-57.
6. Lu XL, Liu ZH, Shen YN, et al. Primary cutaneous zygomycosis caused by rhizomucor variabilis: a new endemic zygomycosis? A case report and review of 6 cases reported from China. Clin Infect Dis 2009; 49:e39-42.
7. Li DM, Lun LD. Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature. Mycopathologia 2012; 174: 429-39.
8. Hemashettar BM, Patil RN, O'Donnell K, Chaturvedi V, Ren P, Padhye AA. Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India. J Clin Microbiol 2011; 49: 2372-5.
9. Cagatay AA, Oncu SS, Calangu SS, Yildirmak TT, Ozsut HH, Eraksoy HH. Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report. BMC Infect Dis 2001; 1: 22.
10. Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998; 26: 1383-96.
11. Lin SY, Lu PL, Tsai KB, et al. A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published. Mycopathologia 2012; 174: 499-504.